Bullock Wealth Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61K Hold
342
– – 0.03% 264
2026
Q1
$32.7K Hold
342
– – 0.02% 306
2025
Q4
$27.5K Hold
342
– – 0.01% 312
2025
Q3
$32.4K Buy
342
+270
+375% +$21.7K 0.02% 299
2025
Q2
$5.18K Sell
72
-70
-49% -$3.99K ﹤0.01% 457
2025
Q1
$7.14K Hold
142
– – ﹤0.01% 420
2024
Q4
$9.92K Hold
142
– – 0.01% 392
2024
Q3
$14.4K Hold
142
– – 0.01% 338
2024
Q2
$20K Buy
142
+72
+103% +$8.3K 0.01% 301
2024
Q1
$7.87K Buy
+70
New +$8.34K 0.01% 382

Other funds holding ACLS

Bullock Wealth Management's ACLS Position: Q2 2026 in Review

Bullock Wealth Management held its Axcelis (ACLS) position steady in Q2 2026 at 342 shares worth $61K. The position accounts for 0.03% of the portfolio, ranked #264.

Bullock Wealth Management first reported a position in ACLS in Q1 2024 and has held it in 10 quarters since. 442 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Bullock Wealth Management held 342 shares of Axcelis worth $61K as of Q2 2026.
  • Bullock Wealth Management left its Axcelis share count unchanged in Q2 2026.
  • Axcelis made up 0.03% of Bullock Wealth Management's portfolio in Q2 2026, its #264 holding.
  • Bullock Wealth Management first reported a position in Axcelis in Q1 2024 and has held it in 10 quarters since.
  • 442 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Bullock Wealth Management's 13F filing for Q2 2026, filed 19 Aug 2026.